-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Yiteng Jiahe (06998.HK) announced that on July 16, 2026, the company has received 484.196 million US dollars of proceeds from the sale. According to the UCB S.A. (UCB) escrow payment agent's notice, such proceeds are part of the price the company is entitled to collect for the sale of all of its shares held in Candid Therapeutics, Inc. (Candid), and was informed of the proposed payment terms by UCB. The sale stemmed from (among others) a merger agreement (merger agreement) between UCB, its consolidated subsidiary, and Candid on May 3, 2026, according to which UCB's consolidated subsidiary would be merged and merged into CandID, while Candid would continue to be the surviving company and become an indirect wholly-owned subsidiary of UCB (merger). As a Candid shareholder bound by a voting agreement (voting agreement) between Candid and its shareholders, the Company is contractually obligated to vote in favor of the merger. After the merger is completed, all Candid shares held by the Company will be automatically converted to the right to receive cash consideration (sale matters) along with the shares held by all other Candid shareholders (excluding dissenting shareholders).

智通財經·07/16/2026 14:41:14
語音播報
Zhitong Finance App News, Yiteng Jiahe (06998.HK) announced that on July 16, 2026, the company has received 484.196 million US dollars of proceeds from the sale. According to the UCB S.A. (UCB) escrow payment agent's notice, such proceeds are part of the price the company is entitled to collect for the sale of all of its shares held in Candid Therapeutics, Inc. (Candid), and was informed of the proposed payment terms by UCB. The sale stemmed from (among others) a merger agreement (merger agreement) between UCB, its consolidated subsidiary, and Candid on May 3, 2026, according to which UCB's consolidated subsidiary would be merged and merged into CandID, while Candid would continue to be the surviving company and become an indirect wholly-owned subsidiary of UCB (merger). As a Candid shareholder bound by a voting agreement (voting agreement) between Candid and its shareholders, the Company is contractually obligated to vote in favor of the merger. After the merger is completed, all Candid shares held by the Company will be automatically converted to the right to receive cash consideration (sale matters) along with the shares held by all other Candid shareholders (excluding dissenting shareholders).